Okahara-Narita Junko, Tsuchiya Hideaki, Takada Tatsuyuki, Torii Ryuzo
Research Center for Animal Life Science, Shiga University of Medical Science, Seta Tsukinowa-cho, Otsu, Shiga, 520-2192, Japan.
Primates. 2007 Jul;48(3):232-40. doi: 10.1007/s10329-006-0032-z. Epub 2007 Jan 12.
In nonhuman primates (NHPs), there have so far been few reports about nuclear transfer (NT), especially using adult somatic cells. The objective of this study was to determine the developmental competence of NT embryos derived from various somatic cells embryonic stem (ES), amniotic epithelial, cumulus, or fetal fibroblast cells] and the nuclear transfer method, such as electro fusion or piezo microinjection, activation with chemical reagent [ionomycine/6-dimethylaminopurine (DMAP), calcium ionophore A23187/DMAP, or cycloheximide (CHX)] and reprogramming time (1, 2, or 4 h; in this study, the duration from injection or fusion to activation was defined as the reprogramming time). Our results showed that a 1-h reprogramming and activation with ionomycin/DMAP are suitable for NT in monkeys. Developing cleaved embryos up to the six-cell stage was similar among all experiments. However, beyond the eight-cell stage, developmental rates were higher in NT embryos reconstructed with fetal fibroblast cells and amniotic epithelial cells, and we were able to produce NT blastocysts from these cells. Interestingly, electro fusion is sufficient for amniotic epithelial cells and piezo microinjection is better suited for fetal fibroblast cells to produce NT blastocysts, thus suggesting that the best method for somatic cell NT may be different between cell types.
在非人灵长类动物(NHPs)中,迄今为止关于核移植(NT)的报道很少,尤其是使用成体细胞的核移植。本研究的目的是确定源自各种体细胞[胚胎干细胞(ES)、羊膜上皮细胞、卵丘细胞或胎儿成纤维细胞]的核移植胚胎的发育能力以及核移植方法,如电融合或压电显微注射,用化学试剂[离子霉素/6-二甲基氨基嘌呤(DMAP)、钙离子载体A23187/DMAP或环己酰亚胺(CHX)]激活以及重编程时间(1、2或4小时;在本研究中,从注射或融合到激活的持续时间定义为重编程时间)。我们的结果表明,1小时的重编程和用离子霉素/DMAP激活适用于猴的核移植。在所有实验中,发育至六细胞期的分裂胚胎情况相似。然而,在八细胞期之后,用胎儿成纤维细胞和羊膜上皮细胞重建的核移植胚胎的发育率更高,并且我们能够从这些细胞中产生核移植囊胚。有趣的是,电融合足以用于羊膜上皮细胞,而压电显微注射更适合用于胎儿成纤维细胞以产生核移植囊胚,因此表明体细胞核移植的最佳方法可能因细胞类型而异。